Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
Paul Goepfert(University of Maryland, Baltimore), Harriet L. Robinson(GeoVax (United States)), David C. Montefiori(Duke University), Marnie Elizaga(Fred Hutch Cancer Center), Susan Buchbinder(University of California, San Francisco), Michael Pensiero(National Institute of Allergy and Infectious Diseases), Georgia D. Tomaras(National Institutes of Health), Bernard Moss(National Institute of Allergy and Infectious Diseases), Beryl A. Koblin(New York Blood Center), Mark J. Mulligan(New York University), Spyros A. Kalams(Vanderbilt University Medical Center), Alicia Sato, Christopher Butler(University of Oxford), M. Juliana McElrath(Fred Hutch Cancer Center), Lindsey R. Baden(Brigham and Women's Hospital), Jorge Sánchez(National University of San Marcos), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Scott M. Hammer, Michael C. Keefer(University of Rochester Medical Center), Javier R. Lama(Asociación Civil Impacta Salud y Educación), Stephen C. DeRosa(Infectious Disease Research Institute), Kelly E. Seaton(International Vaccine Institute)
Cited by 84
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k